Neuropharmacology and Neurobiology Section, Clinical and Experimental Medicine, The Medical School, University of Birmingham, Birmingham, UK.
J Neurochem. 2011 Mar;116(6):975-83. doi: 10.1111/j.1471-4159.2010.07129.x. Epub 2011 Jan 19.
The 5-hydroxytryptamine 3 (5-HT(3)) receptor is a pentameric ligand-gated ion channel with potential molecular isoforms arising from different subunit combinations and/or different post-translational modifications of the individual subunits. Since N-glycosylation of the 5-HT3A subunit impacts cell surface trafficking, the presence of N-glycosylation of the human (h) 5-HT3B subunit and the influence upon cell membrane expression was investigated. Following transient expression of the h5-HT3B subunit by human embryonic kidney cells (HEK293 cells) stably expressing the h5-HT3A subunit, the N-glycosylation inhibitor tunicamycin reduced the size of the predominant h5-HT3B-immunoreactive protein (∼ 55 kDa reduced to ∼ 40 kDa). Disruption of each consensus N-glycosylation sequences in the h5-HT3B subunit (N31S, N75S, N117S, N147S and N182S) resulted in a reduced molecular weight (by ∼ 2-4 kDa) of each mutant when expressed by HEK293 cells stably expressing the h5-HT3A subunit. Immunocytochemical studies demonstrated that disruption of each of the N-glycosylation sequences (individually or combined) reduced the expression of the mutant h5-HT3B subunit protein in the cell membrane when co-expressed with the h5-HT3A subunit. The present study has identified utilised N-glycosylation sites of the h5-HT3B subunit and demonstrated that they promote subunit expression in the cell membrane; a prerequisite for 5-HT(3) receptor function.
5-羟色胺 3(5-HT(3))受体是一种五聚体配体门控离子通道,具有潜在的分子同工型,这些同工型源于不同的亚基组合和/或单个亚基的不同翻译后修饰。由于 5-HT3A 亚基的 N-糖基化影响细胞表面转运,因此研究了人类(h)5-HT3B 亚基的 N-糖基化的存在及其对细胞膜表达的影响。在通过稳定表达 h5-HT3A 亚基的人胚肾细胞(HEK293 细胞)瞬时表达 h5-HT3B 亚基后,N-糖基化抑制剂衣霉素减少了主要 h5-HT3B-免疫反应性蛋白的大小(55 kDa 减少至40 kDa)。在稳定表达 h5-HT3A 亚基的 HEK293 细胞中表达时,破坏 h5-HT3B 亚基中的每个共识 N-糖基化序列(N31S、N75S、N117S、N147S 和 N182S)都会导致每个突变体的分子量降低(约 2-4 kDa)。免疫细胞化学研究表明,当与 h5-HT3A 亚基共表达时,破坏每个 N-糖基化序列(单独或组合)都会减少突变体 h5-HT3B 亚基蛋白在细胞膜中的表达。本研究鉴定了 h5-HT3B 亚基的已利用 N-糖基化位点,并证明它们促进了亚基在细胞膜中的表达;这是 5-HT(3)受体功能的前提。